Allan S. Kaplan

Scientific Advisor at Novamind

Dr. Allan Kaplan is currently a Senior Clinician Scientist at the Center for Addiction and Mental Health (CAMH) in Toronto. At the University of Toronto, Dr. Kaplan is the Vice-Chair for Research and Professor in the Department of Psychiatry and is the Director of the Institute of Medical Science, School of Graduate Studies, Faculty of Medicine. He was the inaugural Loretta Anne Rogers Chair in Eating Disorders at Toronto General Hospital and is currently a Senior Scientist at the Toronto General Research Institute. Dr. Kaplan received his medical, psychiatric and graduate school training at the University of Toronto. He has worked in the field of eating disorders for 30 years, has lectured widely on various topics in the field, published 150 peer-reviewed articles, two books, 50 book chapters and over 200 abstracts. He is the past President of both the Academy for Eating Disorders, the largest organization of eating disorder professionals in the world and the International Eating Disorder Research Society. Dr. Kaplan has been a continuously funded peer-reviewed investigator since 1992 and has received grant support from the National Institute of Mental Health in the USA and the Canadian Institutes of Health Research in Canada.

Location

Toronto, Canada

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.


Industries

Headquarters

Toronto, Canada

Employees

11-50

Links